Inmaculada Heras

Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Español de Tratamiento en Hematología Pediatric-Based Protocol ALL-96

Josep‐María Ribera, Albert Oriol, Miguel Á. Sanz et al. · Journal of Clinical Oncology · 2008 · 261 citations

Medicine, Oncology, Pediatrics +15

Serum Galactomannan Versus a Combination of Galactomannan and Polymerase Chain Reaction-Based Aspergillus DNA Detection for Early Therapy of Invasive Aspergillosis in High-Risk Hematological Patients: A Randomized Controlled Trial

José María Aguado, Lourdes Vázquez, Mario Fernández‐Ruiz et al. · Clinical Infectious Diseases · 2014 · 156 citations · Full text

Life Sciences, Hematology, Microbiology +17

BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors

MD Caballero, Vicente Rubio, J. Rifón et al. · Bone Marrow Transplantation · 1997 · 153 citations

Medicine, Oncology, Chemotherapy +14

The lincRNA<i>HOTAIRM1</i>, located in the<i>HOXA</i>genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature

Marina Díaz‐Beyá, Salut Brunet, Josep Nomdedéu et al. · Oncotarget · 2015 · 130 citations · Full text

Life Sciences, Genetics, Oncology +17

The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease

Javier Corral, Rocío Gónzález‐Conejero, Marı́a Luisa Lozano et al. · British Journal of Haematology · 1997 · 96 citations

Medicine, Genetics, Molecular Genetics +17